GORDON CARL L
SEC Form 4 insider trading activity
GORDON CARL L has filed 5 SEC Form 4 filings (24 transaction rows) across 5 companies, including ADRX, ETRA, BLSM, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 30, 2026.
On the most recent filing, GORDON CARL L is listed as Director, 10% Owner at ADARx Pharmaceuticals, Inc. Inside the rolling window, GORDON CARL L reported 4 open-market purchases totaling $61.1M in ADRX, ETRA, BLSM and 1 more and no open-market sales. The largest disclosed transaction in the window is a purchase of 1,333,333 ETRA shares on Sep 21, 2026, worth $20.0M.
Companies traded
Other insiders at ADRX
Insider Buying
$61.1M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
5
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GORDON CARL L made?
GORDON CARL L has filed 5 SEC Form 4 filings (24 transaction rows) across 5 companies, including ADRX, ETRA, BLSM since 2025.
Which companies does GORDON CARL L trade?
GORDON CARL L has filed SEC Form 4 disclosures for 5 companies, including ADRX, ETRA, BLSM.
When was GORDON CARL L's most recent SEC Form 4 filing?
GORDON CARL L's most recent SEC Form 4 filing on Tracefour is dated Sep 30, 2026.
What is GORDON CARL L's total buy and sell value in the current window?
Inside the rolling retention window, GORDON CARL L bought $61.1M and sold $0 based on SEC Form 4 filings.
What was GORDON CARL L's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,333,333 ETRA shares on 2026-09-21, worth $20.0M, per SEC Form 4 filings.